EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument

Kimberly G Blumenthal, Daniel A Gundersen, Liam R Smith, Brett Nava-Coulter, Andrew King, Elizabeth J Phillips, Alexei Gonzalez-Estrada, Iris M Otani, Allison Ramsey, Aleena Banerji, Timothy G Chow, Cosby A Stone und 2 weitere

Journal of Allergy and Clinical Immunology · 2025-09 · 156 (3) · 734-742

DOI: 10.1016/j.jaci.2025.02.027 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-09. Verfasst von Kimberly G Blumenthal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Bost…. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Medical History Taking. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NIAID NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While the reaction history is critical for drug allergy evaluations and is typically self-reported, there is no validated survey instrument to collect drug allergy history from patients. OBJECTIVE: We validated a survey instrument that collects patient-reported drug allergy history. METHODS: The drug allergy history tool (DAHT) was revised after 3 rounds of cognitive testing, assessed for reliability through test-retest comparisons, and assessed for quality and validity through a concordance analysis against electronic health record allergist documentation. Participants completing testing and surveys had 1 or more drug allergies and were recruited from allergy clinics at Massachusetts General Hospital. Primary evaluative measures were percentage agreement and kappa statistic values. RESULTS: The DAHT was completed by 79 individuals (mean age, 49 [SD 17] years, 85% female, 85% White, 11% Hispanic ethnicity), 29 with single drug allergy labels and 50 with multiple drug allergy labels. The most common drug allergy labels were penicillins (77%), sulfonamides (32%), cephalosporins (15%), and nonsteroidal anti-inflammatory drugs (8%). The DAHT achieved acceptable test-retest reliability (median κ = 0.64, median agreement = 86%). The DAHT achieved a more complete allergy history than allergist documentation in the electronic health record, with lower median item uncertainty (21% DAHT vs 79% electronic health record) with fair concordance (median κ = 0.21, median agreement = 67%) between the two data sources. CONCLUSION: The DAHT is a reliable and valid source of patient-reported drug allergy information. This tool can be used in clinical care and clinical research to obtain standardized patient-reported drug allergy history.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityMedical History TakingHumansFemaleMaleMiddle AgedAdultSurveys and QuestionnairesReproducibility of ResultsSelf ReportAgedElectronic Health Records

Stichwörter der Autor:innen

Drug allergyconsensushypersensitivityquestionnairereactionrisk stratification

Autor:innen und Institutionen

  • Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: kblumenthal@mgh.harvard.edu.
  • Harvard Medical School, Boston, Mass; Survey and Qualitative Methods Core, Dana Farber Cancer Institute, Boston, Mass.
  • Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
  • Survey and Qualitative Methods Core, Dana Farber Cancer Institute, Boston, Mass.
  • Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Center for Drug Safety and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt Univers…

Förderung

  • NHGRI NIH HHS
  • NIAID NIH HHS
  • AHRQ HHS
  • NIH

Zitieren

APA

Blumenthal, K. G., Gundersen, D. A., Smith, L. R., Nava-Coulter, B., King, A., Phillips, E. J., Gonzalez-Estrada, A., Otani, I. M., Ramsey, A., Banerji, A., Chow, T. G., Stone, C. A., Salinas, W. A., & Khan, D. A. (2025). The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument. Journal of Allergy and Clinical Immunology, 156(3), 734-742. https://doi.org/10.1016/j.jaci.2025.02.027

Vancouver

Blumenthal KG, Gundersen DA, Smith LR, Nava-Coulter B, King A, Phillips EJ, et al. The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument. Journal of Allergy and Clinical Immunology. 2025;156(3):734-742. doi:10.1016/j.jaci.2025.02.027

BibTeX
@article{Blumenthal2025,
  author = {Blumenthal, Kimberly G and Gundersen, Daniel A and Smith, Liam R and Nava-Coulter, Brett and King, Andrew and Phillips, Elizabeth J and Gonzalez-Estrada, Alexei and Otani, Iris M and Ramsey, Allison and Banerji, Aleena and Chow, Timothy G and Stone, Cosby A and Salinas, Whitney A and Khan, David A},
  title = {The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  volume = {156},
  number = {3},
  pages = {734--742},
  doi = {10.1016/j.jaci.2025.02.027}
}
Kostenlos starten →